Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus
TW Geisbert, JB Geisbert, A Leung… - Journal of …, 2009 - Am Soc Microbiol
The filoviruses Marburg virus and Ebola virus cause severe hemorrhagic fever with high
mortality in humans and nonhuman primates. Among the most promising filovirus vaccines …
mortality in humans and nonhuman primates. Among the most promising filovirus vaccines …
[HTML][HTML] Transmission of Ebola virus from pigs to non-human primates
HM Weingartl, C Embury-Hyatt, C Nfon, A Leung… - Scientific reports, 2012 - nature.com
Ebola viruses (EBOV) cause often fatal hemorrhagic fever in several species of simian primates
including human. While fruit bats are considered natural reservoir, involvement of other …
including human. While fruit bats are considered natural reservoir, involvement of other …
[HTML][HTML] Stability of SARS-CoV-2 on critical personal protective equipment
The spread of COVID-19 in healthcare settings is concerning, with healthcare workers
representing a disproportionately high percentage of confirmed cases. Although SARS-CoV-2 …
representing a disproportionately high percentage of confirmed cases. Although SARS-CoV-2 …
[HTML][HTML] SARS-CoV-2 infection and transmission in the North American deer mouse
…, M Chan, N Tailor, EJ Mendoza, A Leung… - Nature …, 2021 - nature.com
Widespread circulation of SARS-CoV-2 in humans raises the theoretical risk of reverse
zoonosis events with wildlife, reintroductions of SARS-CoV-2 into permissive nondomesticated …
zoonosis events with wildlife, reintroductions of SARS-CoV-2 into permissive nondomesticated …
[HTML][HTML] Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates
…, MG Lewis, JB Geisbert, A Grolla, A Leung… - PLoS …, 2008 - journals.plos.org
Ebola virus (EBOV) is a significant human pathogen that presents a public health concern as
an emerging/re-emerging virus and as a potential biological weapon. Substantial progress …
an emerging/re-emerging virus and as a potential biological weapon. Substantial progress …
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
…, KJN Williams, JB Geisbert, A Leung… - Journal of …, 2008 - Am Soc Microbiol
Recombinant vesicular stomatitis virus (VSV) vectors expressing homologous filoviral
glycoproteins can completely protect rhesus monkeys against Marburg virus when administered …
glycoproteins can completely protect rhesus monkeys against Marburg virus when administered …
Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs
GP Kobinger, A Leung, J Neufeld… - Journal of Infectious …, 2011 - academic.oup.com
(See the editorial commentary by Bausch, on pages 179–81 .) Background. Reston ebolavirus
was recently detected in pigs in the Philippines. Specific antibodies were found in pig …
was recently detected in pigs in the Philippines. Specific antibodies were found in pig …
N95 mask decontamination using standard hospital sterilization technologies
The response to the COVID-19 epidemic is generating severe shortages of personal
protective equipment around the world. In particular, the supply of N95 respirator masks has …
protective equipment around the world. In particular, the supply of N95 respirator masks has …
[HTML][HTML] Decontamination of N95 masks for re-use employing 7 widely available sterilization methods
A Kumar, SB Kasloff, A Leung, T Cutts, JE Strong… - PloS one, 2020 - journals.plos.org
The response to the COVID-19 epidemic is generating severe shortages of personal
protective equipment around the world. In particular, the supply of N95 respirator masks has …
protective equipment around the world. In particular, the supply of N95 respirator masks has …
[HTML][HTML] Postexposure treatment of Marburg virus infection
…, LE Hensley, JB Geisbert, A Leung… - Emerging infectious …, 2010 - ncbi.nlm.nih.gov
Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus–based
vaccine is administered 20–30 min after infection with Marburg virus. We protected 5/…
vaccine is administered 20–30 min after infection with Marburg virus. We protected 5/…